Placebo matching with 12.5mg clinical trials

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures

This study is testing a new medicine, cenobamate, for people in the UK and other countries who have a specific type of epilepsy seizure called Primary Generalized Tonic-Clonic seizures. Researchers want to see if it reduces how often these seizures happen and if it's safe to use.